World's Best Scientists 2026 revealed!
Wolfgang L. Gross

Wolfgang L. Gross

D-Index & Metrics

Immunology

D-Index
97
Citations
39684
World Ranking
811
National Ranking
52

Medicine

D-Index
103
Citations
43005
World Ranking
7308
National Ranking
411

Overview

Wolfgang L. Gross is affiliated with the University of Lübeck in Germany. The primary focus of their scholarly work spans several fields including Corporate Governance and Law, Vasculitis and related conditions, Otitis Media and Relapsing Polychondritis, Coagulation, Bradykinin, Polyphosphates, and Angioedema, as well as Genomics, phytochemicals, and oxidative stress. Their research also touches upon Mast cells and histamine and Garlic and Onion Studies.

Gross has authored multiple papers, published mainly in reputable venues such as "Die Aktiengesellschaft," "UNC Libraries," and "Frontiers in Immunology." Notable recent papers include:

  • "2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides" (2020, UNC Libraries)
  • "Corrigendum: Sulforaphane promotes dendritic cell stimulatory capacity through modulation of regulatory molecules, JAK/STAT3- and microRNA-signaling" (2022, Frontiers in Immunology)
  • "Wann ist der Bezugsrechtsausschluss bei sog. 'Spitzen' bei einer Kapitalerhöhung erforderlich und wann ist er gerechtfertigt?" (2021, Die Aktiengesellschaft)
  • "Geschlechter- und Frauenquote für Vorstand und Aufsichtsrat nach dem FüPoG II - Ab wann anzuwenden und ab wann berichtspflichtig?" (2021, Die Aktiengesellschaft)
  • "ESG-Studie: Unternehmen im Transformationsprozess" (2022, Die Aktiengesellschaft)

Frequent collaborators in their research include J. Charles Jennette, Ronald J. Falk, P. J. Bacon, Neil Basu, and M. Cinta Cid.

Gross' contributions also extend into book publications, including the forthcoming title "Handbuch börsennotierte AG," expected in 2025 with Verlag Dr. Otto Schmidt eBooks.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

    David Jayne;Niels Rasmussen;Konrad Andrassy;Paul Bacon

  • EULAR Recommendations for the management of primary small and medium vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Paul A Lyons;Tim F Rayner;Sapna Trivedi;Julia U Holle

  • Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

    Kirsten de Groot;Lorraine Harper;David R.W. Jayne;Luis Felipe Flores Suarez

  • Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

    Kirsten De Groot;Niels Rasmussen;Paul A Bacon;Jan Willem Cohen Tervaert

  • An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

    Eva Reinhold-Keller;Nadja Beuge;Ute Latza;Kirsten De Groot

  • Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

    Bernhard Nolle;Ulrich Specks;Jens Lüdemann;Michael S. Rohrbach

  • EULAR recommendations for the management of large vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    Bernhard Hellmich;Oliver Flossmann;Wolfgang L Gross;Paul Bacon

  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin

  • Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

    J Lüdemann;B Utecht;W L Gross

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

    Matthieu Groh;Christian Pagnoux;Chiara Baldini;Elisabeth Bel

  • Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

    C Mukhtyar;O Flossmann;B Hellmich;P Bacon

  • ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

    W L Gross;W H Schmitt;E Csernok

  • Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register

    Eva Reinhold-Keller;Karen Herlyn;Rosemarie Wagner-Bastmeyer;Wolfgang L. Gross

  • Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis

    P Lamprecht;J Voswinkel;T Lilienthal;B Nolle

  • Wegener's autoantigen decoded.

    D. E. Jenne;J. Tschopp;J. Lüdemann;B. Utecht

  • Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

    Julia U. Holle;Wolfgang L. Gross;Ute Latza;Bernhard Nölle

  • A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

    Frank Moosig;Jan Phillip Bremer;Bernhard Hellmich;Julia Ulrike Holle

  • Pulmonary Wegener's Granulomatosis : Correlation Between High-Resolution CT Findings and Clinical Scoring of Disease Activity

    Michael Reuter;Armin Schnabel;Frank Wesner;Kay Tetzlaff

Frequent Co-Authors

Elena Csernok
Elena Csernok University of Manchester
David Jayne
David Jayne University of Cambridge
Raashid Luqmani
Raashid Luqmani University of Oxford
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Alfred Mahr
Alfred Mahr Université Paris Cité
Jörg T. Epplen
Jörg T. Epplen Ruhr University Bochum
Charles D. Pusey
Charles D. Pusey Imperial College London
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Ulrich Specks
Ulrich Specks Mayo Clinic
Vincenzo Cerundolo
Vincenzo Cerundolo University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but seeking diverse career options, exploring related online degrees can open new doors. Nurse Practitioner programs, especially those known as easy nurse practitioner programs to get into, provide flexible pathways for healthcare professionals to expand their expertise while gaining clinical experience.

Mental health is a growing focus within healthcare, and the top pmhnp programs offer specialized psychiatric-mental health training. These programs emphasize clinical placements, ensuring students receive hands-on practice in real-world environments, a critical component for career success.

Cost is often a deciding factor when choosing a program. Many professionals find value in researching the cheapest psych np programs which balance affordability with quality education and opportunities for advancement.

Finally, understanding earning potential can guide career decisions. For example, insights into the highest paid dnp specialties highlight areas of nursing with the strongest financial rewards, helping graduates align their educational paths with long-term goals.

Best Scientists Citing Wolfgang L. Gross

Trending Scientists